Further to an earlier posting about Merck and Elsevier combining on a fake journal, Elsevier now acknowledges that there were six "sponsored article publications."
Elsevier Published Six Fake Journals
May 8, 2009
Share this post
2 Comments
Law Bytes
Episode 199: Boris Bytensky on the Criminal Code Reforms in the Online Harms Act
byMichael Geist
April 15, 2024
Michael Geist
April 8, 2024
Michael Geist
March 25, 2024
Michael Geist
March 18, 2024
Michael Geist
March 11, 2024
Michael Geist
Search Results placeholder
Recent Posts
- The Law Bytes Podcast, Episode 199: Boris Bytensky on the Criminal Code Reforms in the Online Harms Act
- AI Spending is Not an AI Strategy: Why the Government’s Artificial Intelligence Plan Avoids the Hard Governance Questions
- The Law Bytes Podcast, Episode 198: Richard Moon on the Return of the Section 13 Hate Speech Provision in the Online Harms Act
- Tweets Are Not Enough: Why Combatting Relentless Antisemitism in Canada Requires Real Leadership and Action
- The Law Bytes Podcast, Episode 197: Divest, Ban or Regulate? – Anupam Chander on the Global Fight Over TikTok
Use bugmenot to read the article
If you do not want to register just to read an article, use bugmenot.com to enter the-scientist site.
Sick and tired of walled gardens like Elsevier? Support Science Commons
http://sciencecommons.org/about/
Quote:
There are petabytes of research data being produced in laboratories around the world, but the best web search tools available can’t help us make sense of it. Why? Because more stands between basic research and meaningful discovery than the problem of search.
Many scientists today work in relative isolation, left to follow blind alleys and duplicate existing research. Data are balkanized — trapped behind firewalls, locked up by contracts or lost in databases that can’t be accessed or integrated. Materials are hard to get — universities are overwhelmed with transfer requests that ought to be routine, while grant cycles pass and windows of opportunity close. It’s not uncommon for research sponsors to invest hundreds of millions of dollars in critically important efforts like drug discovery, only to see them fail.
The consequences in many cases are no less than tragic. The time it takes to go from identifying a gene to developing a drug currently stands at 17 years — forever, for people suffering from disease.